直肠癌新辅助治疗后临床完全缓解的临床评估

The clinical evaluation of clinical complete response to neoadjuvant chemoradiotherapy for rectal cancer

  • 摘要: 术前新辅助治疗已成为进展期直肠癌标准治疗模式,新辅助治疗之后的完全缓解病例可以免除外科手术所带来的并发症和功能损害。但是,目前对于手术之前评估的临床完全缓解与术后得到的病理完全缓解存在较大差异。如何准确评估完全缓解病例成为目前的热点。直肠指检、内镜检查在评估黏膜完整性方面较为直观,但是灵敏度差;直肠超声和MRI检查能够从结构和功能上评估肿瘤细胞的残留与否,但是也面临灵敏度低的问题;其他如PET-CT和穿刺活组织检查难以满足临床需求。

     

    Abstract: Neochemoradiotherapy has been implemented in the multidisciplinary therapy for advanced rectal cancer. The patients with complete response after neothemoradiation could avoid surgical resection and thereafter might be free of surgical complications, as well as functional impairment. However, the preoperative evaluated clinical complete response is not equally to the pathologic complete response after surgery. The accurate methods to evaluate the status of complete response remained controversy. Based on the digital rectal examination and endoscopic observation, rectal MRI and endorectal ultrasound could verify the integrity of mucosa and the structural changes in rectal wall. These preoperative staging methods, as well as PET-CT and needle biopsy, had been widely used, but with a low sensitivity.

     

/

返回文章
返回